Exact Sciences has extended and made amendments to its agreement with Pfizer to promote Cologuard, the company announced recently. “We’re thrilled to continue working with Pfizer to increase screening rates with…
Exact Sciences‘ Oncotype DX Genomic Prostate Score (GPS) test is a strong independent predictor of critical outcomes in UFI-risk prostate cancer patients, the company announced today. The results of the study–which included 299…
Exact Sciences is one of four organizations to participate in Gov. Tony Evers’ new public-private partnership to increase Wisconsin’s laboratory testing capacity for COVID-19, the governor announced recently. According to…
Exact Sciences has acquired Paradigm Diagnostics and Viomics to extend its lab testing and research and development capabilities, the company announced recently. According to a release, Paradigm offers a comprehensive…
The U.S. Food and Drug Administration approved Exact Sciences‘ Cologuard for use by eligible average-risk individuals ages 45 and older, the company announced today. Previously, the FDA had approved use…
Exact Sciences will acquire Genomic Health, a provider of genomic-based diagnostic tests that help optimize cancer care, in a cash and stock transaction valued at $2.8 billion, the company announced today. According to…
Exact Sciences opened its new 169,000-square foot clinical lab on the west side of Madison this week, the company announced recently. “Madison, Wisconsin is the home of earlier cancer detection,”…
Exact Sciences, along with the Mayo Clinic, reports that early research using blood-based methylated DNA markers demonstrate a potential to achieve 92% sensitivity and 92% specificity for detecting the most…
Exact Sciences announced today that former U.S. Department of Health and Human Services Secretary Kathleen Sebelius has joined its board of directors. “Secretary Sebelius understands the value of detecting cancer earlier, as…
More than two million Americans have been screened for colorectal cancer using Exact Sciences‘ Cologuard, the company announced today. “Cologuard is changing how Americans get screened for colorectal cancer and,…
